
|Articles|June 1, 2007
Second-generation antipsychotics offer mixed results: Finding most effective antipsychotic drug can be trial and error process
Antipsychotics are the fourth largest group of medications prescribed in the United States today, with a collective cost of approximately $10 billion. Newer, second-generation medications represent 90% of the current market, and they cost considerably more than older antipsychotics.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The FDA proposes ditching comparative efficacy studies for biosimilars
2
Atopic dermatitis care advances in 2025 with new biologics, topicals and oral therapies
3
Misdiagnosis of Type 1 diabetes remains a major problem, despite advances
4
UC Davis develops new drug for bladder cancer patients
5


















































